Inspira Enterprise, a global leader in cybersecurity services, today announced that it has been recognized as a Leader in Everest Group's Cybersecurity Services for Mid-Market Enterprises PEAK Matrix® Assessment 2025. This recognition highlights Inspira's AI-driven cybersecurity services, tailored specifically for mid-market enterprises globally. https://mma.prnewswire.com/media/2400111/Inspira_Enterprise_Logo.jpg Commenting on the achievement, Chetan Jain, Managing Director, Inspira Enterprise, remarked, […]

Celebrating Thai wellness, culture, and sustainability under TAT's new global campaign Healing is the New Luxury The Tourism Authority of Thailand (TAT) is presenting Thailand's distinctive blend of wellness, culture, and sustainability at the World Travel Market (WTM) 2025, held from 4-6 November at ExCeL London. Marking Thailand's 44th year of participation in this leading

Achieved Record Total Revenue of $182 Million and Dealer Revenue Growth of 2% Year-over-Year Accelerating Marketplace Adoption Grew Customer Base +271 Year-over-Year to 19,526 Dealer Customers Marketplace Supported Record Year-to-Date Traffic and the Launch of CarsonTM AI-Powered Search Features Repurchased $64 Million of Stock Year-to-Date, On Track with $70 to $90 Million Target for FY25

CAPLYTA®, in combination with an oral antidepressant, demonstrated superior efficacy with a favorable safety and tolerability profile consistent with established indications1,2 In pivotal trials, CAPLYTA® did not increase mean weight gain, metabolic changes, or reported sexual side effects1,2 In a six-month open-label extension safety study, safety profile was consistent with pivotal studies and 80% of

As the Hong Kong daily “HongKong Telegraph” recently learned, the SCANDICTRUSTGROUP, an internationally operating conglomerate that is not active in the hotel industry, is expanding its international sales network: After successfully passing a thorough KYC and AML check (process control to verify identity, prevent moneylaundering, terrorism financing and all corporate activities) by bankers, the Dubai-based

(NYSE:PH), CLEVELAND, Nov. 06, 2025 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended September 30, 2025, that included the following highlights (compared with the prior year period): Fiscal 2026 First Quarter Highlights: Sales were a record $5.1 billion; organic sales

(CNSX:URM),(CNSX:URM.CN),(Boerse Frankfurt – Freiverkehr:IOR),(OTC US:NIOMF),(Other OTC:NIOMF), Vancouver, BC,, Nov. 06, 2025 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“First American Uranium”, or the “Company”) is pleased to announce that it will proceed with a non-brokered private placement of up to 1,811,594 flow-through common shares in the capital of the

(NASDAQ:CBIO), IND Submission for CR-001, a PD-1 x VEGF Bispecific Antibody, on Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with Solid Tumors Advancing ADCs in the Pipeline, with IND Submission for CR-002 on Track for Mid-2026 WALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) — Crescent Biopharma,

(NASDAQ:RNTX), AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, announced that a new preprint has been posted to medRxiv describing clinical and translational findings from an inhaled, dose-escalation

(NASDAQ:LXRX), FDA End-of-Phase 2 meeting for pilavapadin in DPNP to be held by year-end All IND-enabling studies of LX9851 for obesity completed and submitted to licensee Novo Nordisk Site initiation for SONATA-HCM Phase 3 study of sotagliflozin in both obstructive and non-obstructive HCM completed; enrollment completion on target for 2026 Additional data in support of